4.8 Article

Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming

期刊

CELL REPORTS
卷 24, 期 6, 页码 1496-+

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2018.07.026

关键词

-

资金

  1. MRC Research Capacity Building PhD studentship [1092244]
  2. Wellcome Trust Institutional Strategic Support Fund (ISSF) [097825/Z/11/B]
  3. Wellcome Trust ISSF grant [097825/Z/11/B, 097825/Z/11/A]
  4. MRC [MR/N008715/1, MR/K017047/1] Funding Source: UKRI
  5. Wellcome Trust [097825/Z/11/A, 097825/Z/11/B] Funding Source: Wellcome Trust

向作者/读者索取更多资源

During somatic reprogramming, Yamanaka's pioneer factors regulate a complex sequence of molecular events leading to the activation of a network of pluripotency factors, ultimately resulting in the acquisition and maintenance of a pluripotent state. Here, we show that, contrary to the pluripotency factors studied so far, overexpression of Mybl2 inhibits somatic reprogramming. Our results demonstrate that Mybl2 levels are crucial to the dynamics of the reprogramming process. Mybl2 overexpression changes chromatin conformation, affecting the accessibility of pioneer factors to the chromatin and promoting accessibility for early immediate response genes known to be reprogramming blockers. These changes in the chromatin landscape ultimately lead to a deregulation of key genes that are important for the mesenchymal-to-epithelial transition. This work defines Mybl2 level as a gatekeeper for the initiation of reprogramming, providing further insights into the tight regulation and required coordination of molecular events that are necessary for changes in cell fate identity during the reprogramming process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据